FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

39021311000001109: Co-amoxiclav 250mg/125mg dispersible tablets sugar free (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Co-amoxiclav 250mg/125mg dispersible tablets sugar free
\UK product\Virtual therapeutic moiety\Co-amoxiclav\Co-amoxiclav 250mg/125mg dispersible tablets sugar free

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Product containing penicillin (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg dispersible tablets sugar free
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg dispersible tablets sugar free
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg dispersible tablets sugar free

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1615121000001111 Co-amoxiclav 250mg/125mg dispersible tablets sugar free en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1615141000001118 Co-amoxiclav 250mg/125mg dispersible tablets sugar free (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Is a	Co-amoxiclav	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has specific active ingredient	Clavulanate potassium	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has specific active ingredient	Amoxicillin trihydrate	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has dispensed dose form	Dispersible tablet	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Amoxicillin	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	suspension.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Clavulanic acid	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Is a	Co-amoxiclav	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Augmentin 375mg dispersible tablets (GlaxoSmithKline)	Is a	True	Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet	Has VMP	True	Co-amoxiclav 250mg/125mg dispersible tablets sugar free	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1615121000001111	Co-amoxiclav 250mg/125mg dispersible tablets sugar free	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1615141000001118	Co-amoxiclav 250mg/125mg dispersible tablets sugar free (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module